In-Vitro Diagnostics Market Global Report 2017

In-vitro diagnostics (IVD) are used to detect diseases, infections, and conditions and also monitor a person’s state of health and therapeutic procedures by examining specimens derived from the human body such as tissue, blood, stools, urine and the other body fluids. Significant technologies incorporated in in-vitro diagnostics are polymerase chain reaction, microarray techniques, sequencing technology and mass spectrometry, which are used for test sample preparation. In-vitro diagnostic medical devices include reagents, reagent products, control materials, calibration materials, kits, instruments, apparatus, systems, equipment, pregnancy tests, urine test strips, blood sugar monitoring systems for diabetics and receptacles for medical specimens.

Americas was the largest region in the In-Vitro Diagnostics market in 2016, accounting for over 45% of the market share. Asia was the second largest region accounting for over 22% of the market share. Europe was the third largest region accounting for over 20% of the market share.

Companies in this market are very active with multiple strategic collaborations and agreements. Top companies in the in-vitro diagnostic market are strategically partnering and collaborating with other companies to broaden their products, technologies and services. For instance, In February 2015, Roche acquired Signature Diagnostics to strengthen its cancer diagnostics effort with Signature’s expertise in both next-generation sequencing (NGS) assays and biobanks. In February 2014, Thermo Fisher Scientific acquired the Life Technologies Corporation to transform into a major player in the segment of next-generation sequencing space

1. In-Vitro Diagnostics Market Characteristics;

2. In-Vitro Diagnostics Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;

3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

4. In-Vitro Diagnostics Market Customer Information;

5. In-Vitro Diagnostics Market Segmentation;
5.1. Global In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 5.2. Global In-Vitro Diagnostics Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global In-Vitro Diagnostics Market Trends And Strategies; Strategic Collaborations And Agreements; New Product Launches; Rising Demand for Point-of-Care (POC) Testing; 5.4 Global In-Vitro Diagnostics Market Compared With Similar Markets, 2016; 5.5 Global In-Vitro Diagnostics Market Compared With Similar Markets, 2012 – 2020, Historic and Forecast; 5.6 In-Vitro Diagnostics Market Compared With Similar Markets, 2016, By Region; 5.7. In-Vitro Diagnostics Market Compared With Similar Markets, 2016, By Country; 5.8 Point-Of-Care Diagnostics; 5.8.1 Market Characteristics; 5.8.2. Global Point-Of-Care Diagnostics Market, 2016, By Segment; 5.8.3. Market Trends And Strategies; 5.9 Immunochemistry; 5.9.1. Market Characteristics; 5.9.2. Global Immunochemistry Market, 2016, By Segment; 5.9.3. Market Trends And Strategies; 5.10 Clinical Chemistry; 5.10.1. Market Characteristics; 5.10.2. Global Clinical Chemistry Market, 2016, By Segment; 5.10.3. Market Trends And Strategies; 5.11 Molecular Diagnostics; 5.11.1. Market Characteristics; 5.11.2. Global Molecular Diagnostics Market, 2016, By Segment; 5.11.3. Market Trends And Strategies; 5.12 Microbiology; 5.12.1. Market Characteristics; 5.12.2. Global Microbiology Market, 2016, By Segment; 5.12.3. Market Trends And Strategies; 5.13 Hemostasis; 5.13.1. Market Characteristics; 5.13.2. Global Hemostasis Market, 2016, By Segment; 5.13.3. Market Trends And Strategies; 5.14 Hematology And Immunohematology; 5.14.1. Market Characteristics; 5.14.2. Global Hematology And Immunohematology Market, 2016, By Segment; 5.14.3. Market Trends And Strategies;

6. In-Vitro Diagnostics Market Regional And Country Analysis;
6.1. Global In-Vitro Diagnostics Market, 2016, By Region; 6.2. Global In-Vitro Diagnostics Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. In-Vitro Diagnostics Market, 2016, By Country; 6.4. In-Vitro Diagnostics Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Healthcare Market Segments, 2016, By Region; 6.6. Global Medical Equipment Market Segments, 2016, By Region; 6.7. Global Healthcare Market Segments, 2016, By Country; 6.8. Global Medical Equipment Market Segments, 2016, By Country

7. Global In-Vitro Diagnostics Market Comparison With Macro Economic Factors;
7.1. In-Vitro Diagnostics Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average In-Vitro Diagnostics Expenditure, Global; 8. In-Vitro Diagnostics Market Comparison With Macro Economic Factors Across Countries; 8.1. In-Vitro Diagnostics Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average In-Vitro Diagnostics Expenditure, By Country;

9. In-Vitro Diagnostics Market Comparison With Industry Metrics; 9.1. Global Number Of Medical Labs, 2016, By Country; 9.2. Global In-Vitro Diagnostics Market Revenue Versus Number Of Medical Labs, 2016, By Country;

10. Asia-Pacific In-Vitro Diagnostics Market;
10.1.1. Asia-Pacific In-Vitro Diagnostics Market Overview; 10.1.2. Asia-Pacific In-Vitro Diagnostics Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific In-Vitro Diagnostics Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.2. Asia-Pacific In-Vitro Diagnostics Market: Country Analysis; 10.3. China In-Vitro Diagnostics Market; 10.3.1. China In-Vitro Diagnostics Market Overview; 10.3.2. China In-Vitro Diagnostics Historic Market, 2012 - 2016; 10.3.3. China In-Vitro Diagnostics Forecast Market, 2016 - 2020; 10.3.4. China In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.3.5. China In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020; 10.4. India In-Vitro Diagnostics Market; 10.4.1. India In-Vitro Diagnostics Market Overview; 10.4.2. India In-Vitro Diagnostics Historic Market, 2012 - 2016; 10.4.3. India In-Vitro Diagnostics Forecast Market, 2016 - 2020; 10.4.4. India In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.4.5. India In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020; 10.5. Japan In-Vitro Diagnostics Market; 10.5.1. Japan In-Vitro Diagnostics Market Overview; 10.5.2. Japan In-Vitro Diagnostics Historic Market, 2012 - 2016; 10.5.3. Japan In-Vitro Diagnostics Forecast Market, 2016 - 2020; 10.5.4. Japan In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.5.5. Japan In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020; 10.6. Australia In-Vitro Diagnostics Market; 10.6.1. Australia In-Vitro Diagnostics Historic Market, 2012 - 2016; 10.6.2. Australia In-Vitro Diagnostics Forecast Market, 2016 - 2020; 10.6.3. Australia In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 10.6.4. Australia In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020;

11. Western Europe In-Vitro Diagnostics Market;
11.1.1. Western Europe In-Vitro Diagnostics Market Overview; 11.1.2. Western Europe In-Vitro Diagnostics Historic Market, 2012 - 2016; 11.1.3. Western Europe In-Vitro Diagnostics Forecast Market, 2016 - 2020; 11.1.4. Western Europe In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 11.2. Western Europe In-Vitro Diagnostics Market: Country Analysis; 11.3. UK In-Vitro Diagnostics Market; 11.3.1. UK In-Vitro Diagnostics Market Overview; 11.3.2. UK In-Vitro Diagnostics Historic Market, 2012 - 2016; 11.3.3. UK In-Vitro Diagnostics Forecast Market, 2016 - 2020; 11.3.4. UK In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 11.3.5. UK In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020; 11.4. Germany In-Vitro Diagnostics Market; 11.4.1. Germany In-Vitro Diagnostics Historic Market, 2012 - 2016; 11.4.2. Germany In-Vitro Diagnostics Forecast Market, 2016 - 2020; 11.4.3. Germany In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 11.4.4 Germany In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020; 11.5 France In-Vitro Diagnostics Market; 11.5.1 France In-Vitro Diagnostics Historic Market, 2012 - 2016; 11.5.2 France In-Vitro Diagnostics Forecast Market, 2016 - 2020; 11.5.3 France In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 11.5.4 France In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020; 11.6. Italy In-Vitro Diagnostics Market; 11.6.1. Italy In-Vitro Diagnostics Historic Market, 2012 - 2016; 11.6.2. Italy In-Vitro Diagnostics Forecast Market, 2016 - 2020; 11.6.3. Italy In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 11.6.4. Italy In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020; 11.7. Spain In-Vitro Diagnostics Market; 11.7.1. Spain In-Vitro Diagnostics Historic Market, 2012 - 2016; 11.7.2. Spain In-Vitro Diagnostics Forecast Market, 2016 - 2020; 11.7.3. Spain In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 11.7.4. Spain In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020;

12. Eastern Europe In-Vitro Diagnostics Market;
12.1.1. Eastern Europe In-Vitro Diagnostics Market Overview; 12.1.2. Eastern Europe In-Vitro Diagnostics Historic Market, 2012 - 2016; 12.1.3. Eastern Europe In-Vitro Diagnostics Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 12.2. Eastern Europe In-Vitro Diagnostics Market: Country Analysis; 12.3. Russia In-Vitro Diagnostics Market; 12.3.1. Russia In-Vitro Diagnostics Historic Market, 2012 - 2016; 12.3.2. Russia In-Vitro Diagnostics Forecast Market, 2016 - 2020; 12.3.3. Russia In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 12.3.4. Russia In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020;

13. North America In-Vitro Diagnostics Market;
13.1.1. North America In-Vitro Diagnostics Market Overview; 13.1.2. North America In-Vitro Diagnostics Historic Market, 2012 - 2016; 13.1.3. North America In-Vitro Diagnostics Forecast Market, 2016 - 2020; 13.1.4. North America In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; 13.2. North America In-Vitro Diagnostics Market: Country Analysis; 13.3. USA In-Vitro Diagnostics Market; 13.3.1. USA In-Vitro Diagnostics Historic Market, 2012 - 2016; 13.3.2. USA In-Vitro Diagnostics Forecast Market, 2016 - 2020; 13.3.3 USA In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 13.3.4. USA In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020;

14. South America In-Vitro Diagnostics Market;
14.1.1. South America In-Vitro Diagnostics Market Overview; 14.1.2. South America In-Vitro Diagnostics Historic Market, 2012 - 2016; 14.1.3. South America In-Vitro Diagnostics Forecast Market, 2016 - 2020; 14.1.4. South America In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 14.2. South America In-Vitro Diagnostics Market: Country Analysis; 14.3. Brazil In-Vitro Diagnostics Market; 14.3.1. Brazil In-Vitro Diagnostics Historic Market, 2012 - 2016; 14.3.2. Brazil In-Vitro Diagnostics Forecast Market, 2016 - 2020; 14.3.3. Brazil In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology; 14.3.4. Brazil In-Vitro Diagnostics Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average In-Vitro Diagnostics Expenditure, 2012 - 2020;

15. Middle East In-Vitro Diagnostics Market;
15.1.1. Middle East In-Vitro Diagnostics Market Overview; 15.1.2. Middle East In-Vitro Diagnostics Historic Market, 2012 - 2016; 15.1.3. Middle East In-Vitro Diagnostics Forecast Market, 2016 - 2020; 15.1.4. Middle East In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology;

16. Africa In-Vitro Diagnostics Market;
16.1.1. Africa In-Vitro Diagnostics Market Overview; 16.1.2. Africa In-Vitro Diagnostics Historic Market, 2012 - 2016; 16.1.3. Africa In-Vitro Diagnostics Forecast Market, 2016 - 2020; 16.1.4. Africa In-Vitro Diagnostics Market, 2016, By Segment; Point-Of-Care Diagnostics; Immunochemistry; Clinical Chemistry; Molecular Diagnostics; Microbiology; Hemostasis; Hematology And Immunohematology;

17. In-Vitro Diagnostics Market Competitive Landscape;
17.1. Company Profiles; 17.2. F. Hoffmann-La Roche Ltd; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Siemens Healthineers; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. Danaher (Beckman Coulter Inc); 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Abbott Laboratories Inc.; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Thermo Fisher Scientific; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

18. Key Mergers And Acquisitions In The In-Vitro Diagnostics Market;

19. Market Background: Medical Equipment Market;
19.1.1. Medical Equipment Market Characteristics; 19.1.2. Medical Equipment Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Medical Equipment Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Medical Equipment Trends And Strategies; 19.2. Medical Equipment Market Regional And Country Analysis; 19.2.1. Global Medical Equipment Market, 2016, By Region; 19.2.2. Global Medical Equipment Market, 2012 - 2020, Historic And Forecast, By Region; 19.3.3. Medical Equipment Market, 2016, By Country; 19.2.4. Medical Equipment Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Medical Equipment Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Medical Equipment Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Medical Equipment Market Comparison With Macro Economic Factors; 19.3.1. Medical Equipment Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Medical Equipment Expenditure, Global; 19.4. Medical Equipment Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Medical Equipment Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Medical Equipment Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Medical Equipment Market;

20. Healthcare Industry Financial Margins;

21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer